[1]
2018. Role of intranasal midazolam as a procedural sedative in children aged 6 months to 12 years: An open-label randomized controlled study. Indian Journal of Child Health. 5, 1 (Jan. 2018), 1–5. DOI:https://doi.org/10.32677/IJCH.2018.v05.i01.001.